169 related articles for article (PubMed ID: 8442111)
1. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation.
Smyth LA; Herrmann RP; Christiansen FT; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
Transplant Proc; 1993 Feb; 25(1 Pt 2):1276-8. PubMed ID: 8442111
[No Abstract] [Full Text] [Related]
2. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation.
Smyth LA; Witt CS; Christiansen FT; Herrmann RP; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
Bone Marrow Transplant; 1993 Oct; 12(4):351-5. PubMed ID: 8275034
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors influence the development of acute graft-versus-host disease in adults undergoing allogeneic bone marrow transplantation.
Smyth LA; Herrmann RP; Christiansen FT; Witt CS; Townend DC; Dawkins RL
Transplant Proc; 1992 Oct; 24(5):2269. PubMed ID: 1413052
[No Abstract] [Full Text] [Related]
4. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
Mickelson EM; Anasetti C; Yoon Choo S; Longton GM; Petersdorf EW; Martin PJ; Hansen JA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1239-40. PubMed ID: 8442101
[No Abstract] [Full Text] [Related]
5. Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank.
Mizuno S; Ohta H; Kamijima S; Kato Y; Maruya E; Saji H; Kamiya T; Kodera Y; Morishima Y
Transplant Proc; 1995 Feb; 27(1):1383-4. PubMed ID: 7878921
[No Abstract] [Full Text] [Related]
6. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
7. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
[TBL] [Abstract][Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
9. Probability of finding a matched donor for bone marrow transplantation in a Chinese population: two year experience of an all-Chinese marrow donor registry.
Hawkins BR; Dunbar MM; Liang R; Chiu E; Lie A; Chan TK
Transplant Proc; 1995 Feb; 27(1):1375-6. PubMed ID: 7878916
[No Abstract] [Full Text] [Related]
10. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
11. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.
Rufer N; Tiercy JM; Breur-Vriesendorp B; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Speiser D; Gratwohl A; Chapuis B
Bone Marrow Transplant; 1995 Nov; 16(5):641-6. PubMed ID: 8547860
[TBL] [Abstract][Full Text] [Related]
12. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of marrow from donors other than genotypically HLA-identical siblings.
de Gast GC; Verdonck LF; Dekker AW; Mudde GC
Neth J Med; 1987 Aug; 31(1-2):77-82. PubMed ID: 3309695
[No Abstract] [Full Text] [Related]
14. Utility of DRB1 subtyping: a case report.
Lower FE; Jennings CD; Phillips GL; Thompson JS
Clin Transplant; 1996 Dec; 10(6 Pt 2):598-600. PubMed ID: 8996749
[TBL] [Abstract][Full Text] [Related]
15. MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome.
Kitcharoen K; Witt CS; Romphruk AV; Christiansen FT; Leelayuwat C
Hum Immunol; 2006 Mar; 67(3):238-46. PubMed ID: 16698448
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of HLA typing and retyping data in patients with bone marrow transplantation].
Wölpl A; Fischer M; Eiermann T; Goldmann SF
Beitr Infusionsther Transfusionsmed; 1994; 32():266-9. PubMed ID: 9480105
[TBL] [Abstract][Full Text] [Related]
17. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
19. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
[TBL] [Abstract][Full Text] [Related]
20. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
